US Stock MarketDetailed Quotes

LGVN Longeveron

Watchlist
  • 1.730
  • -0.050-2.80%
Trading Mar 26 11:56 ET
25.83MMarket Cap-0.66P/E (TTM)

About Longeveron Company

Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.

Company Profile

SymbolLGVN
Company NameLongeveron
Listing DateFeb 12, 2021
Issue Price10.00
Founded2014
CEOMr. Mohamed Wael Ahmed Hashad
MarketNASDAQ
Employees26
Fiscal Year Ends12-31
AddressLife Science & Technology Park,1951 Northwest 7th Avenue,Suite 250
CityMiami
ProvinceFlorida
CountryUnited States of America
Zip Code33136
Phone1-305-909-0840
Websitehttp://www.longeveron.com

Company Executives

  • Name
  • Position
  • Salary
  • Mohamed Wael Ahmed Hashad
  • Chief Executive Officer and Director
  • 1.85M
  • Dr. Nataliya Agafonova
  • Chief Medical Officer
  • --
  • Lisa Locklear
  • Treasurer, Executive Vice President, Chief Financial Officer and Principal Accounting Officer
  • 1.12M
  • Devin Blass
  • Chief Technology Officer and Senior Vice President of Chemistry, Manufacturing, and Controls
  • --
  • Dr. Joshua M. Hare, M.D.
  • Chief Science Officer and Chairman of the Board
  • 640.39K
  • Lisa McClain-Moss
  • Vice President, Manufacturing
  • --
  • Rock Soffer
  • Director
  • 101.56K
  • Ursula Ungaro
  • Independent Director
  • 113.81K
  • Khoso Baluch
  • Independent Director
  • 120.31K
  • Dr. Roger Hajjar
  • Independent Director
  • 56.26K
  • Richard N. Kender, M.B.A.
  • Independent Director
  • 60.23K
  • Neha Motwani
  • Independent Director
  • 56.13K
  • Paul Lehr
  • General Counsel and Secretary
  • 1.23M
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
+0.97%
KB Home
KBH
+0.82%
Taylor Morrison Home
TMHC
+0.53%
Petroleo Brasileiro SA Petrobras
PBR
+0.56%
Lennar Corp
LEN
+0.37%

Unlock the Full List